-+ 0.00%
-+ 0.00%
-+ 0.00%

ESTRELLA IMMUNOPHARMA ANNOUNCES LATE-BREAKING ORAL PRESENTATION OF PHASE 1 STARLIGHT-1 DATA FOR EB103 AT THE 2026 TANDEM MEETINGS OF ASTCT® & CIBMTR®

Reuters·02/03/2026 13:00:05

Please log in to view news